Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy."Biocon, Quark get DCGI nod for trials of new eye disease drug
Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy."
0 коммент.:
Отправить комментарий